Look For Institutional Buying In XPeng Inc ADR (NYSE: XPEV)

XPeng Inc ADR (XPEV) concluded trading on Wednesday at a closing price of $20.37, with 6.32 million shares of worth about $128.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 69.05% during that period and on June 04, 2025 the price saw a gain of about 3.77%. Currently the company’s common shares owned by public are about 775.87M shares, out of which, 755.00M shares are available for trading.

Stock saw a price change of 5.38% in past 5 days and over the past one month there was a price change of 2.16%. Year-to-date (YTD), XPEV shares are showing a performance of 72.34% which increased to 145.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.60 but also hit the highest price of $27.16 during that period. The average intraday trading volume for XPeng Inc ADR shares is 10.96 million. The stock is currently trading 1.28% above its 20-day simple moving average (SMA20), while that difference is up 3.03% for SMA50 and it goes to 34.47% higher than SMA200.

XPeng Inc ADR (NYSE: XPEV) currently have 775.87M outstanding shares and institutions hold larger chunk of about 14.87% of that.

The stock has a current market capitalization of $15.81B and its 3Y-monthly beta is at 2.57. It has posted earnings per share of -$0.75 in the same period. It has Quick Ratio of 1.07 while making debt-to-equity ratio of 0.58. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for XPEV, volatility over the week remained 3.32% while standing at 4.40% over the month.

Stock’s fiscal year EPS is expected to rise by 77.85% while it is estimated to increase by 196.46% in next year.

Coverage by Nomura stated XPeng Inc ADR (XPEV) stock as a Buy in their note to investors on March 19, 2025, suggesting a price target of $30 for the stock. On March 19, 2025, Daiwa Securities Downgrade their recommendations, while on March 10, 2025, Citigroup Upgrade their ratings for the stock with a price target of $29. Stock get a Neutral rating from UBS on February 24, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.